Skip to main content

Table 4 Clinical presentations and treatments for chronic dialysis patients versus patients with normal renal function

From: Epidemiology and outcomes of Endophthalmitis in chronic dialysis patients: a 13-year experience in a tertiary referral center in Taiwan

  Dialysis Control
  Endogenous (N = 25) Exogenous (N = 7) Endogenous (N = 31) Exogenous (N = 26)
Clinical & laboratory
 Days from symptom onset to ophthalmologists’ visit 1–30 (Median: 2 days) 1–7 (Median: 2 days) 1–30 (Median: 3 days) 1–30 (Median: 3 days)
 Recent trauma or surgery 0 0% 7 100.0% 0 0% 26 100.0%
 Days post eye surgery    3–20 (Median: 4 days)    1–35 (Median: 4 days)
 Blurred vision 14 56% 2 28.5% 26 83.9% 25 96.2%
 Ophthalmalgia 25 100%# 7 100%* 22 71.0% 20 76.9%
 Peri-ocular swelling 25 100%# 6 85.7%* 10 32.2% 2 7.6%
 Fever 8 32.0% 0 0% 17 54.8% 0 0%
 Septic shock 2 8.0% 0 0% 5 16.1% 0 0%
 Respiratory failure 2 8.0% 0 0% 1 3.2% 0 0%
 Dialysis access infection 4 14.8% 0 0% 0 0% 0 0%
 Leukocytosis 11 ± 5 10 ± 6 10 ± 4 11 ± 5
 Serum CRP level 71 ± 75 16 ± 10 133 ± 105 43 ± 56
Microbiology
 Bacteremia 8 32.0% 0 0% 13 41.9% 0 0%
 Fungemia 0 0 0 0% 0 0% 0 0%
 Positive vitreous culture 13 52.0% 4 57.1% 18 58.1% 19 73.1%
Treatment
 IVI 12 48.0%+ 7 100% 29 93.5% 25 96.2%
 TPPV 2 8.0% 3 42.9% 2 6.5% 10 38.5%
 Enucleation 5 20.0% 0 0% 6 19.4% 1 3.8%
 Parenteral antibiotic only 8 32.0% 0 0% 0 0% 0 0%
  1. CRP C-Reactive protein, IVI intra-vitreous injection, TPPV trans pars plana vitrectomy
  2. # p < 0.05 Endogenous: Dialysis v.s. Control
  3. *p < 0.05 Exogenous: Dialysis v.s. Control
  4. + p < 0.05 Endogenous: Dialysis v.s. Control
\